U.S. Investigational Device Exemption (IDE) Study
-
Regulatory
Orthofix Announces First Patient Implant in the M6-C Artificial Cervical Disc Two-Level IDE Study
August 2, 2021 LEWISVILLE, Texas–(BUSINESS WIRE)–Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus,…
Read More » -
Spine
Full Two-Year Data from Orthofix M6-C Artificial Cervical Disc Study Shows Significant Improvement in Pain, Function and Quality of Life Scores
April 04, 2019 LEWISVILLE, Texas–(BUSINESS WIRE)–Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company focused on musculoskeletal products and therapies,…
Read More »